Mas Arantxa, Masip Josep
Critical Care Department, Consorci Sanitari Integral (CSI), Hospital Sant Joan Despí Moisès Broggi and Hospital General de l'Hospitalet, University of Barcelona, Barcelona, Spain.
Int J Chron Obstruct Pulmon Dis. 2014 Aug 11;9:837-52. doi: 10.2147/COPD.S42664. eCollection 2014.
After the institution of positive-pressure ventilation, the use of noninvasive ventilation (NIV) through an interface substantially increased. The first technique was continuous positive airway pressure; but, after the introduction of pressure support ventilation at the end of the 20th century, this became the main modality. Both techniques, and some others that have been recently introduced and which integrate some technological innovations, have extensively demonstrated a faster improvement of acute respiratory failure in different patient populations, avoiding endotracheal intubation and facilitating the release of conventional invasive mechanical ventilation. In acute settings, NIV is currently the first-line treatment for moderate-to-severe chronic obstructive pulmonary disease exacerbation as well as for acute cardiogenic pulmonary edema and should be considered in immunocompromised patients with acute respiratory insufficiency, in difficult weaning, and in the prevention of postextubation failure. Alternatively, it can also be used in the postoperative period and in cases of pneumonia and asthma or as a palliative treatment. NIV is currently used in a wide range of acute settings, such as critical care and emergency departments, hospital wards, palliative or pediatric units, and in pre-hospital care. It is also used as a home care therapy in patients with chronic pulmonary or sleep disorders. The appropriate selection of patients and the adaptation to the technique are the keys to success. This review essentially analyzes the evidence of benefits of NIV in different populations with acute respiratory failure and describes the main modalities, new devices, and some practical aspects of the use of this technique.
在实施正压通气后,通过接口进行的无创通气(NIV)的使用大幅增加。第一种技术是持续气道正压通气;但是,在20世纪末引入压力支持通气后,这成为了主要模式。这两种技术,以及最近引入的一些整合了某些技术创新的其他技术,已广泛证明在不同患者群体中能更快改善急性呼吸衰竭,避免气管插管,并促进传统有创机械通气的撤机。在急性情况下,NIV目前是中重度慢性阻塞性肺疾病加重以及急性心源性肺水肿的一线治疗方法,对于免疫功能低下且有急性呼吸功能不全的患者、撤机困难的患者以及预防拔管后呼吸衰竭的患者也应予以考虑。此外,它还可用于术后、肺炎和哮喘病例或作为姑息治疗。NIV目前广泛应用于各种急性情况,如重症监护和急诊科、医院病房、姑息治疗或儿科病房以及院前护理。它也被用作慢性肺部或睡眠障碍患者的家庭护理疗法。正确选择患者并使其适应该技术是成功的关键。本综述主要分析了NIV在不同急性呼吸衰竭患者群体中的益处证据,并描述了主要模式、新设备以及该技术使用的一些实际方面。